PRESS RELEASE published on 12/09/2024 at 20:17, 1 year 9 months ago EUROAPI entame un nouveau chapitre avec une nouvelle gouvernance et un nouveau management EUROAPI entame un nouveau chapitre avec une nouvelle gouvernance et un nouveau management. Emmanuel Blin nommé Président du Conseil d’administration et David Seignolle nommé Directeur général. Perspectives 2024 maintenues Gouvernance Management EUROAPI Emmanuel Blin David Seignolle
BRIEF published on 10/16/2024 at 07:05, 1 year 10 months ago Appointment of Olivier Falut as Financial Director of EUROAPI Appointment Financial Director EUROAPI Olivier Falut FOCUS-27 Transformation
BRIEF published on 10/16/2024 at 07:05, 1 year 10 months ago Nomination d'Olivier Falut comme Directeur financier d'EUROAPI Nomination Directeur Financier EUROAPI Olivier Falut Transformation FOCUS-27
PRESS RELEASE published on 10/16/2024 at 07:00, 1 year 10 months ago Olivier Falut appointed EUROAPI’s Chief Financial Officer Olivier Falut appointed EUROAPI's Chief Financial Officer. He brings 30 years of financial management experience in the industrial sector. EUROAPI focuses on innovative active ingredient solutions for global health Chief Financial Officer Industrial Sector EUROAPI Active Ingredient Solutions Olivier Falut
PRESS RELEASE published on 10/16/2024 at 07:00, 1 year 10 months ago Olivier Falut est nommé Directeur financier d’EUROAPI Olivier Falut nommé Directeur financier d’EUROAPI. Anciens postes chez Lactalis, Fareva. Expérience de 30 ans. EUROAPI, leader principes actifs pharmaceutiques Directeur Financier Secteur Industriel EUROAPI Olivier Falut Principes Actifs
BRIEF published on 10/10/2024 at 20:43, 1 year 11 months ago EUROAPI secures financing for its FOCUS-27 plan Funding Sanofi EUROAPI Hybrid Bond FOCUS-27 Plan
BRIEF published on 10/10/2024 at 20:43, 1 year 11 months ago EUROAPI sécurise le financement de son plan FOCUS-27 Financement Sanofi EUROAPI Obligation Hybride Plan FOCUS-27
PRESS RELEASE published on 10/10/2024 at 20:38, 1 year 11 months ago EUROAPI completes the financing of its FOCUS-27 plan and moves forward with its execution EUROAPI completes financing of FOCUS-27 plan, refinancing €451M Credit Facility & issuing €200M Hybrid Bond, enhancing collaboration with Sanofi Financing Partnership Sanofi EUROAPI FOCUS-27
PRESS RELEASE published on 10/10/2024 at 20:38, 1 year 11 months ago EUROAPI finalise le financement de son plan FOCUS-27 et poursuit son exécution EUROAPI finalise le financement de son plan FOCUS-27 avec un nouveau crédit RCF de €451M, une Obligation Hybride Super Subordonnée de €200M souscrite par Sanofi, et un accord de €54M pour réserver une capacité minimale avec Sanofi Financement Accord Sanofi EUROAPI FOCUS-27
PRESS RELEASE published on 08/02/2024 at 19:37, 2 years 1 month ago Rapport Financier Semestriel 2024
Published on 09/12/2026 at 02:35, 11 hours 13 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 14 hours 48 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 15 hours 43 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 16 hours 23 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 20 hours 48 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 07:30, 6 hours 18 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 15 hours 33 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 15 hours 38 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 18 hours 3 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 19 hours 33 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 1 day 6 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 6 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 18 hours ago Availability of the 2026 Interim Financial Report